T cell Activation

T cell activation is a crucial checkpoint in adaptive immunity, and this activation depends on the binding parameters that govern the interactions between T cell receptors and peptide-MHC complexes. Here is the latest research.

January 23, 2021

Chimeric Antigen Receptor T-cell Therapy for Melanoma.

Expert Review of Clinical Immunology
Azadehsadat RazaviNima Rezaei
January 23, 2021

Novel Anti-PD-L1 Peptide Selected from Combinatorial Phage Library Inhibits Tumor Cell Growth and Restores T-Cell Activity.

Journal of Drug Targeting
Raheleh TooyserkaniDennis W P M Löwik
January 24, 2021

Loss of the Transfer RNA Wobble Uridine-Modifying Enzyme Elp3 Delays T Cell Cycle Entry and Impairs T Follicular Helper Cell Responses through Deregulation of Atf4.

The Journal of Immunology : Official Journal of the American Association of Immunologists
Pierre LemaitreChristophe J Desmet
January 26, 2021
Open Access

CD80 on Human T Cells Is Associated With FoxP3 Expression and Supports Treg Homeostasis.

Frontiers in Immunology
Blagoje SoskicDavid M Sansom
January 24, 2021
Preprint
Open Access

Cohesin Releasing Factor WAPL Regulates Genome Structure and Function of Mature T Cells

BioRxiv : the Preprint Server for Biology
Y. SunPavan Reddy
January 26, 2021
Open Access

Profiling the Blood Compartment of Hematopoietic Stem Cell Transplant Patients During Human Cytomegalovirus Reactivation.

Frontiers in Cellular and Infection Microbiology
Biana BernshteinMichal Schwartz
January 21, 2021
Open Access

Characterization of Urine Stem Cell-Derived Extracellular Vesicles Reveals B Cell Stimulating Cargo.

International Journal of Molecular Sciences
Asmaa A ZidanPlinio R Hurtado
January 26, 2021

Immunophenotype of Vestibular Schwannomas.

Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
Wenya Linda BiIan F Dunn
January 22, 2021
Preprint
Open Access

A two-color haploid genetic screen identifies novel host factors involved in HIV latency

BioRxiv : the Preprint Server for Biology
M. RölingTokameh Mahmoudi
January 23, 2021
Open Access

T cell receptor-dependent S-acylation of ZAP-70 controls activation of T cells.

The Journal of Biological Chemistry
Ritika TewariAskar M Akimzhanov
January 26, 2021
Open Access

The Breast Tumor Microenvironment: Could Silicone Breast Implant Elicit Breast Carcinoma?

Breast Cancer : Targets and Therapy
Eduardo FleuryGabriel Salum D'Alessandro

Sign up to follow this feed and discover related papers.

Related Feeds

Antibodies: Agglutination

Antibody-mediated agglutination is the clumping of cells in the presence of antibody, which binds multiple cells together. This enhances the clearance of pathogens. Find the latest research on antibody-mediated agglutination here.

Antibodies: Complement Activation

The complement system can be activated by antigen-associated antibody. In the classical pathway of complement activation, C1q, C4b, and C3b are all able to bind to the Fc portion of IgG or IgM. Find the latest research on antibodies and complement activation here.

Antibody Development

Development of antibodies require integration of knowledge with respect to target antigen properties, antibody design criteria such as affinity, isotype selection, Fc domain engineering, and antibody cross-reactivity across species from the early stages of antibody development. Here is the latest research.


Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.

Antibody synthesis

Antibodies have various functions including neutralization of pathogens, tumor targeting, as well as its utility in biomedical research. Here is the latest research on antibody synthesis.

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

Antibody-Dependent Enhancement

Antibody-dependent enhancement of viral infection is the entry of virus into host cells mediated by antiviral antibodies interacting with Fc or complement receptors. This has been most extensively observed with the dengue virus. Find the latest research on antibody-dependent enhancement here.

Antigenic Modulation

Antigenic modulation occurs when an antibody cross-links antigens on a cell surface, causing the antigens to become internalized. This can lead to therapeutic failure of monoclonal antibodies as the expression of the antigen becomes decreased on target cells. Find the latest research on antigenic modulation here.

B cell Activation

B cell activation is initiated by the ligation of the B cell receptor with antigen and ultimately results in the production of protective antibodies against potentially pathogenic invaders. Here is the latest research.

B cell Differentiation

Depending on the signal received through the B cell receptor and other receptors, B cells differentiate into follicular or marginal zone B cells. Here is the latest research pertaining to this differentiation process.

© 2021 Meta ULC. All rights reserved
/feed-previews/t-cell-activation/0c005bac-4fdf-489d-b13f-52bd4d60f2b9